Comprehensive medication guide to {drug} including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Dextroamphetamine is a central nervous system (CNS) stimulant approved by the FDA for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and Narcolepsy. It is the dextro-isomer of amphetamine and is available as a generic medication as well as under brand names including Dexedrine, Zenzedi, and ProCentra.
Dextroamphetamine helps improve focus, attention, and impulse control in patients with ADHD, and reduces excessive daytime sleepiness in patients with narcolepsy. It is available in immediate-release tablets, extended-release capsules, and an oral solution.
Dextroamphetamine works by increasing the release and blocking the reuptake of two key neurotransmitters in the brain: dopamine and norepinephrine. It also has a minor effect on inhibiting monoamine oxidase. By raising the concentration of these neurotransmitters in the synaptic cleft, Dextroamphetamine improves attention, focus, wakefulness, and executive function.
The immediate-release formulation typically begins working within 30–60 minutes and lasts 4–6 hours, while extended-release capsules provide effects for up to 8–12 hours.
Dextroamphetamine has a findability score of 35 out of 100, meaning it is frequently difficult to find in stock at pharmacies. The ongoing amphetamine shortage — which began in October 2022 — continues to affect supply in 2026. While the DEA increased the Aggregate Production Quota for d-amphetamine to 26.5 million grams in October 2025, experts say this still falls short of actual demand. Many pharmacies report intermittent stock-outs, especially for certain strengths and the extended-release formulation.
If your pharmacy is out of stock, Medfinder can help you locate a pharmacy near you that currently has Dextroamphetamine available.
Struggling to find {drug} in stock? We'll call the pharmacies, sit on hold, and find you one that can fill your prescription.

Because Dextroamphetamine is a Schedule II controlled substance, it must be prescribed by a licensed healthcare provider with DEA registration. Common prescribing specialties include:
Telehealth providers can also prescribe Dextroamphetamine, though regulations vary by state. Some states require an in-person visit for initial Schedule II prescriptions.
Yes. Dextroamphetamine is classified as a Schedule II controlled substance by the DEA due to its high potential for abuse and dependence. This means:
The FDA boxed warning notes that misuse of amphetamines may cause sudden death and serious cardiovascular events. Patients should take Dextroamphetamine exactly as prescribed.
Serious side effects that require immediate medical attention include chest pain, shortness of breath, signs of psychosis (hallucinations, paranoia), new or worsening mood/behavioral changes, and numbness or color changes in fingers and toes (Raynaud's phenomenon).
If you cannot find Dextroamphetamine in stock or your provider recommends a change, these are common alternatives:
Always consult your prescriber before switching medications. Use Medfinder to check availability of these alternatives near you.
Dextroamphetamine has several important drug interactions:
Always inform your doctor and pharmacist of all medications, supplements, and vitamins you take.
Dextroamphetamine remains an effective and widely prescribed treatment for ADHD and narcolepsy, but the ongoing stimulant shortage makes finding it in stock a real challenge for patients in 2026. With a findability score of just 35 out of 100, many patients are forced to call multiple pharmacies or go without their medication.
If you're struggling to find Dextroamphetamine, Medfinder can help you locate pharmacies with current stock near you — no more endless phone calls. You can also save money using discount cards like GoodRx and SingleCare, which can bring the cash price down to as low as $30–$45 for a 30-day supply of generic IR tablets.